New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
11:17 EDTVRTX, MUStocks with call strike movement; VRTX MU
Vertex (VRTX) April 85 call option implied volatility increased 4% to 72, Micron (MU) April 24 call option implied volatility increased 5% to 52 according to IVolatility.
News For VRTX;MU From The Last 14 Days
Check below for free stories on VRTX;MU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
07:24 EDTVRTXVertex management to meet with Deutsche Bank
Subscribe for More Information
06:45 EDTMUMobile DRAM bit growth to reach 37.5% in 2H14, DigiTimes Research reports
Subscribe for More Information
September 17, 2014
07:09 EDTVRTXVertex price target raised to $127 from $103 at Deutsche Bank
Subscribe for More Information
September 16, 2014
09:36 EDTMUActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL NFLX TSLA YHOO FB PBR MU AA TWTR WMT
September 15, 2014
11:56 EDTMUStocks with call strike movement; MU GILD
Subscribe for More Information
September 14, 2014
18:10 EDTMUMicron looks to expand to autos and wearables, WSJ says
Subscribe for More Information
September 10, 2014
10:44 EDTMUMicron mentioned positively at Raymond James
09:27 EDTVRTXVertex shares likely to advance further, says RBC Capital
Subscribe for More Information
September 9, 2014
11:47 EDTVRTXStocks with call strike movement; FSLR VRTX
First Solar (FSLR) March 80 call option implied volatility increased 2% to 42, Vertex (VRTX) January 105 call option implied volatility increased 6% to 41 according to IVolatility.
07:22 EDTMURaymond James to hold a conference
North American Equities Conference to be held in London, England on September 9.
September 8, 2014
11:05 EDTVRTXOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
September 5, 2014
10:05 EDTVRTXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:41 EDTVRTXVertex upgraded to Buy from Neutral at Goldman
Goldman Sachs upgraded Vertex Pharmaceuticals to Buy saying it sees a 90% probability of approval for the company's VX-809/Kalydeco combo for cystic fibrosis and a higher likelihood of M&A following the positive Phase 3 data in June. Goldman raised its price target for shares to $131 from $109.
September 4, 2014
12:50 EDTMUMicron's Adams says market different now due to consolidation, diversification
Subscribe for More Information
06:53 EDTMUMicron reinstated with a Buy at Deutsche Bank
Deutsche Bank reinstated shares of Micron with a Buy rating saying the company's improved profitability and free cash flow generation are sustainable. The firm has a $40 price target for shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use